Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.
  • الفعاليات
  • الأخبار
  • الرؤى
  • الحساب
Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

News

Categories

  • الأحدث
  • أشباه الموصلات
  • الأمن السيبراني
  • التكنولوجيا المالية
  • الدفاع
  • الذكاء الاصطناعي والتقنية
  • الرعاية الصحية
  • الروبوتات
  • الزراعة
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الطاقة والتنقل
  • سلسلة الإمداد

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • الأحدث
  • الذكاء الاصطناعي والتقنية
  • الأمن السيبراني
  • أشباه الموصلات
  • الروبوتات
  • التكنولوجيا المالية
  • الطاقة والتنقل
  • الدفاع
  • الرعاية الصحية
  • سلسلة الإمداد
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الزراعة

الأخبار

الرعاية الصحية

أحدث أخبار الرعاية الصحية والإعلانات والتحليلات من المؤتمرات والمعارض والقمم التي تشكّل القطاع.

الأحدث في القسم

STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more

Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

Eyepoint disclosed that a Phase 3 trial of its experimental treatment for a common cause of age-related blindness fell short of its primary goal

(opens original source in a new tab)
Ed Silverman·18 August 2026
STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition (opens original source in a new tab)
STAT News

STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition

Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.

(opens original source in a new tab)
Auzzy Byrdsell — Boston Globe·17 August 2026
STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise (opens original source in a new tab)
STAT News

STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.

(opens original source in a new tab)
Adam Feuerstein·17 August 2026
STAT+: The IRS is probing UnitedHealth, and a private equity slowdown (opens original source in a new tab)
STAT News

STAT+: The IRS is probing UnitedHealth, and a private equity slowdown

UnitedHealth faces an investigation over tax payments, and we examine why PE deals for doctor groups are slowing.

(opens original source in a new tab)
Bob Herman·17 August 2026
STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit (opens original source in a new tab)
STAT News

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·17 August 2026
STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more

AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks

(opens original source in a new tab)
Ed Silverman·17 August 2026
Everything the Trump administration did on health care last week (opens original source in a new tab)
STAT News

Everything the Trump administration did on health care last week

An executive order remaking the federal vaccine agenda, Epic's antitrust lawsuits, and more health news from Morning Rounds

(opens original source in a new tab)
Theresa Gaffney·17 August 2026
STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map (opens original source in a new tab)
STAT News

STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map

Epic, whose software is used by the majority of American hospitals, faces unprecedented challenges ahead of its annual User Group Meeting.

(opens original source in a new tab)
Brittany Trang and Casey Ross·17 August 2026
STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West (opens original source in a new tab)
STAT News

STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West

The California trip shows how Kennedy likes to focus on key MAHA themes, while avoiding some divisive topics.

(opens original source in a new tab)
Chelsea Cirruzzo·17 August 2026
STAT+: UnitedHealth faces IRS probe over potential tax avoidance (opens original source in a new tab)
STAT News

STAT+: UnitedHealth faces IRS probe over potential tax avoidance

The health insurer may face a significant increase in taxes, amid a dispute with federal authorities.

(opens original source in a new tab)
Bob Herman·17 August 2026
Opinion: We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide (opens original source in a new tab)
STAT News

Opinion: We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide

“North Carolina proved that pragmatism can beat partisanship,” write Mandy Cohen and Kody Kinsley.

(opens original source in a new tab)
Mandy Cohen and Kody Kinsley·17 August 2026
STAT+: State laws may be curbing private equity takeovers of physician group (opens original source in a new tab)
STAT News

STAT+: State laws may be curbing private equity takeovers of physician group

Private equity deals for practice management firms are declining sharply.

(opens original source in a new tab)
Tara Bannow·17 August 2026

الأكثر قراءة

  1. 01

    STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more

  2. 02

    STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition

  3. 03

    STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise

  4. 04

    STAT+: The IRS is probing UnitedHealth, and a private equity slowdown

  5. 05

    STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Next
  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.

أسبوع فعاليات الصناعة، يُوصَّل كل جمعة.

بريد إلكتروني قصير واحد. أبرز القصص من المعارض التجارية والمؤتمرات والقمم التي تشكّل الأعمال حول العالم. بلا حشو، بلا بريد عشوائي، إلغاء الاشتراك في أي وقت.